ATE215824T1 - Mittel zur verminderung des augeninnendrucks - Google Patents

Mittel zur verminderung des augeninnendrucks

Info

Publication number
ATE215824T1
ATE215824T1 AT96938475T AT96938475T ATE215824T1 AT E215824 T1 ATE215824 T1 AT E215824T1 AT 96938475 T AT96938475 T AT 96938475T AT 96938475 T AT96938475 T AT 96938475T AT E215824 T1 ATE215824 T1 AT E215824T1
Authority
AT
Austria
Prior art keywords
agents
reducing internal
agent
eye pressure
ocular tension
Prior art date
Application number
AT96938475T
Other languages
English (en)
Inventor
Hajimu Kurumatani
Ayako Kawashima
Masafumi Isogaya
Hisanori Wakita
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE215824T1 publication Critical patent/ATE215824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Window Of Vehicle (AREA)
  • Prostheses (AREA)
  • Laser Surgery Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96938475T 1995-11-14 1996-11-14 Mittel zur verminderung des augeninnendrucks ATE215824T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29578995 1995-11-14
PCT/JP1996/003351 WO1997017974A1 (en) 1995-11-14 1996-11-14 Ocular depressor

Publications (1)

Publication Number Publication Date
ATE215824T1 true ATE215824T1 (de) 2002-04-15

Family

ID=17825188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938475T ATE215824T1 (de) 1995-11-14 1996-11-14 Mittel zur verminderung des augeninnendrucks

Country Status (11)

Country Link
US (1) US6127413A (de)
EP (1) EP0795331B1 (de)
KR (1) KR19980701417A (de)
CN (1) CN1127342C (de)
AT (1) ATE215824T1 (de)
AU (1) AU717104B2 (de)
CA (1) CA2210255A1 (de)
DE (1) DE69620573T2 (de)
ES (1) ES2171742T3 (de)
NO (1) NO973122L (de)
WO (1) WO1997017974A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734650B2 (en) * 1996-05-07 2001-06-21 Toray Industries, Inc. Ophthalmic preparations
US20090016981A1 (en) 2006-05-03 2009-01-15 Allergan, Inc. Therapeutic compounds
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
DK2343292T3 (da) 2008-09-10 2014-11-03 Asahi Glass Co Ltd Nyt prostaglandin 12-derivat
ES2593229T3 (es) * 2010-03-08 2016-12-07 Kaken Pharmaceutical Co., Ltd. Nuevo agonista de EP4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476684A1 (fr) * 1980-02-21 1981-08-28 Interox Procede pour inhiber la corrosion d'appareils en titane
EP0232776B1 (de) * 1986-01-24 1990-10-24 Toray Industries, Inc. 2,5,6,7-Tetranor-4,8-inter-M-phenylen-PGI2-Derivate
DE3886936T2 (de) * 1987-10-16 1994-04-28 Toray Industries 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
AU734650B2 (en) * 1996-05-07 2001-06-21 Toray Industries, Inc. Ophthalmic preparations

Also Published As

Publication number Publication date
WO1997017974A1 (en) 1997-05-22
DE69620573D1 (de) 2002-05-16
EP0795331B1 (de) 2002-04-10
DE69620573T2 (de) 2002-08-08
ES2171742T3 (es) 2002-09-16
EP0795331A4 (de) 1999-07-14
CN1177926A (zh) 1998-04-01
NO973122D0 (no) 1997-07-04
CN1127342C (zh) 2003-11-12
CA2210255A1 (en) 1997-05-22
US6127413A (en) 2000-10-03
AU7587396A (en) 1997-06-05
AU717104B2 (en) 2000-03-16
EP0795331A1 (de) 1997-09-17
NO973122L (no) 1997-08-27
KR19980701417A (ko) 1998-05-15

Similar Documents

Publication Publication Date Title
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
ATE480240T1 (de) Zusammensetzung enthaltend latanoprost und behandlungsmethode von erhöhtem augeninnendruck und glaukom
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
BR0310047A (pt) Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
EP1110554A4 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
SG42446A1 (en) Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom
ATE162074T1 (de) Oculare hypotensive mittel
ATE453395T1 (de) 3, 7 oder 3 und 7 thia- oder oxaprostansäure derivate als mittel zur senkung des augeninnendrucks
FR2754712B1 (fr) Compositions ophtalmiques
CA2505086A1 (en) Ophthalmic compositions for treating ocular hypertension
ATE215824T1 (de) Mittel zur verminderung des augeninnendrucks
MX9401350A (es) Agente para profilaxis o tratamiento de cataratas.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
CA2266363A1 (en) Corneal subepithelial opacity inhibitor
BR0212151A (pt) Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas
EP1364953A4 (de) Triazolochinazolin- und pyrazolotriazolopyrimidinderivate, medizinische zusammensetzungen, mittel mit adenosin-a3-rezeptoraffinität, mittel, die den augeninnendruck senken, zubereitungen zur prävention und behandlung von glaukom und verfahren zur senkung des augeninnendrucks"
ATE289817T1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
WO2001082913A3 (en) Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties